New neurons continue to be generated in the subgranular zone of the dentate gyrus of the adult mammalian hippocampus [1][2][3][4][5] . This process has been linked to learning and memory, stress and exercise, and is thought to be altered in neurological disease [6][7][8][9][10] . In humans, some studies have suggested that hundreds of new neurons are added to the adult dentate gyrus every day
, whereas other studies find many fewer putative new neurons [12] [13] [14] . Despite these discrepancies, it is generally believed that the adult human hippocampus continues to generate new neurons. Here we show that a defined population of progenitor cells does not coalesce in the subgranular zone during human fetal or postnatal development. We also find that the number of proliferating progenitors and young neurons in the dentate gyrus declines sharply during the first year of life and only a few isolated young neurons are observed by 7 and 13 years of age. In adult patients with epilepsy and healthy adults (18-77 years; n = 17 postmortem samples from controls; n = 12 surgical resection samples from patients with epilepsy), young neurons were not detected in the dentate gyrus. In the monkey (Macaca mulatta) hippocampus, proliferation of neurons in the subgranular zone was found in early postnatal life, but this diminished during juvenile development as neurogenesis decreased. We conclude that recruitment of young neurons to the primate hippocampus decreases rapidly during the first years of life, and that neurogenesis in the dentate gyrus does not continue, or is extremely rare, in adult humans. The early decline in hippocampal neurogenesis raises questions about how the function of the dentate gyrus differs between humans and other species in which adult hippocampal neurogenesis is preserved.
We used 59 post-mortem and post-operative samples of the human hippocampus (Supplementary Table 1 ) to investigate the presence of progenitor cells and young neurons from fetal to adulthood stages. At 14 gestational weeks, at the peak of proliferation in the fetal dentate gyrus (DG) 15 
SOX2
+ cells in the hippocampus were found in the hilus . By this age, most young neurons (DCX + PSA-NCAM + cells), were concentrated in the granule cell layer (GCL) proximal to the dNE (Fig. 1c) . By contrast, the distal GCL contained higher numbers of mature NeuN + neurons (Extended Data Fig. 1g, h ), suggesting a gradient of maturation.
To look for the formation of a proliferative subgranular zone (SGZ), we characterized dividing and progenitor cells in the human DG from fetal development to adulthood. At 22 gestational weeks, + cells were predominantly observed in the hilus and next to the distal GCL (Figs 1b, 2a) . By early postnatal life, + cells remained distributed throughout the hilus and GCL (Fig. 2a) . The number of Ki-67
Sox2
+ cells decreased in the hilus during the first year of life ( Fig. 2b-d ), but these cells did not form a discrete layer beneath the GCL at any of the ages studied ( Fig. 2a-d ). There were rare instances of SOX2 +
Ki-67
+ cells in the DG of a 35-year-old individual, but these cells were BLBP − and were dispersed throughout the hippocampus. Light and electron microscopy images of samples obtained from individuals at 22 gestational weeks, birth and 7, 18 and 48 years of age did not reveal a layer of cells with progenitor characteristics adjacent to the GCL 3) . Ki-67
+

BLBP
+ cells were found in the developing DG during fetal and early postnatal stages, but BLBP + cells were − in juvenile and adult brains and were located primarily in the molecular layer (Extended Data Figs 1a, 2b) . Furthermore, immunostaining for nestin, vimentin or GFAP in brain sections from individuals that were 7 years of age and older did not show cells next to the DG or in the hilus that had the typical neural progenitor/stem cell morphology of radial astrocytes (also known as radial or type-I cells) 3, 4, 18 . BLBP and vimentin were depleted from the hilus and were predominantly expressed in mature stellar astrocytes in the molecular layer in brains from individuals that were 7 years of age and older. GFAP-expressing cells that remained in the adult hilus were stellate ALDH1L1 + astrocytes with thin fibres that extended through the hilus and GCL (Extended Data Figs 3a, d, 4) . These cells were not Ki-67 + or found in mitosis. These results indicate that a germinal SGZ does not form next to the human GCL, and that proliferating cells, which express progenitor/stem cell markers, are mostly depleted from the hilus by 7 years of age.
We next investigated the presence of young neurons in the postnatal, human DG. At birth, DCX + PSA-NCAM + cells were located across the GCL, frequently in clusters (Fig. 3a, b) Fig. 5 ). DCX + cells in the DG of infants (1 year old or less) not only expressed PSA-NCAM, but also frequently had the simple elongated morphology of young neurons (Extended Data Fig. 5b ). By contrast, light and electron microscopy images of sections from the brain of a 7-year-old individual showed that the DG contained DCX + cells in different stages of maturation (Extended Data Fig. 6a ). DCX + cells in the hippocampus of a 13-year-old individual had a more mature morphology (Fig. 3e ), expressed NeuN and had distinct axons and dendrites (Extended Data Fig. 5c ). We examined hippocampuses of 17 individuals that were between 18 and 77 years old when they died (Supplementary Table 1 ) for evidence of young neurons. In two adults (sample numbers 24 and 26), we also studied the ventricular wall and found rare DCX + cells with a migratory morphology in the ventricular-subventricular zone 19, 20 , providing a positive control (Extended Data Fig. 6b ). We found no evidence of DCX + PSA-NCAM + young neurons in the hilus or GCL of the hippocampuses from these individuals (Extended Data Figs 5d, 6b) . At three weeks of age, there were many DCX +
TUJ1
+ young neurons in the GCL, however, we did not detect these cells at 19 or 36 years of age. In adults, we observed TUJ1
+ fibres that belonged to many mature neurons (Extended Data  Fig. 6c ). PSA-NCAM + cells were present in the hilus and GCL of adult brains, but these cells had a mature neuronal morphology and were NeuN + (Extended Data Fig. 5d-f ). Using single-molecule in situ hybridization labelling of DCX transcripts, we detected many DCX + cells in the GCL at 14 gestational weeks, but only weak signal in very few, widely distributed cells at 13 years (Extended Data Fig. 6d) . A subpopulation of cells with round nuclei was occasionally labelled by DCX antibodies. These DCX + cells had multiple processes, were not restricted to the hippocampus, expressed the glial markers IBA1 or OLIG2, and had ultrastructural features of glia (Extended Data Fig. 7) .
We also analysed the proliferation of progenitor cells and the presence of young neurons in surgical resections of patients with epilepsy that contained the hippocampus (Supplementary Table 1 ). In these samples, Ki-67
+ or Ki-67
+ cells were present in the hilus and GCL of a 10-month-old individual, but were absent from the sample of an 11-year-old individual (Extended Data Fig. 8a, b) . We also found many DCX + PSA-NCAM + cells at 10 months, whereas only a few cells per section were found in samples from a 7-year-old individual and none were found in 13 surgical resections from individuals that were older than 11 years of age (Extended Data Fig. 8c-g ). There was no evidence of a discrete layer of dividing cells or young neurons in any of the adult cases with epilepsy that we studied.
We next searched for proliferative progenitors and young neurons in the rhesus macaque (M. mulatta). Early studies 2 , in which thymidine-labelling was used, found no evidence of newly generated neurons in adult macaques (17 years old), but subsequent work 21 using injections of 5-bromodeoxyuridine (BrdU, a thymidine analogue that labels newly generated cells) were used, have suggested that low levels of neurogenesis occur, even in the DG of 23-year-old monkeys. At embryonic day (E)150, we observed remnants of the migratory stream between the dNE and the proximal blade of the developing DG (Extended Data Fig. 9a ). + and DCX + cells consolidated into a layer in the SGZ between E150 and birth ( Fig. 4 and Extended Data Fig. 9a-c) . Between birth and 1.5 years of age, the number of Ki-67 + cells decreased eightfold and the macaque SGZ became less defined (Fig. 4a) . The average number of proliferating cells decreased 35-fold between 1.5 and 7 years of age (Fig. 4e) . A continuous SGZ was not detected in macaques that were older than 7 years. Instead, isolated, small, dark cells and occasional + cells were observed next to the GCL (Fig. 4a and Extended Data Fig. 9b) . Similarly, the number of DCX + PSA-NCAM + young neurons decreased during this period, becoming sparse and discontinuous by 7 years of age ( Fig. 4b-d, f) . Most DCX +
PSA-NCAM
+ cells in samples from macaques that were 5 years and older had round nuclei and extensive dendritic trees (Fig. 4c, d and Extended Data Fig. 9d ), but some retained the elongated morphology and ultrastructure of young neurons (Fig. 4d, g ). Although DCX + cells in the DG of 22-and 23-year-old macaques were rare, they were readily found in the ventricular-subventricular zone and rostral migratory stream 22 (Extended Data Fig. 9e ). We next used BrdU to + Ki-67 + cells in the hilus and GCL (arrows). c, Distribution of DCX + PSA-NCAM + cells at 14 gestational weeks and 22 gestational weeks. The arrow indicates the end of the GCL most proximal to the dNE. The distal end of the GCL contained fewer young neurons (arrowhead). Scale bars, 1 mm (a, b (middle)) and 100 μ m (a, b (right), c). Staining was replicated at least three times (n = 1 at 14 gestational weeks; n = 3 at 22 gestational weeks).
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label recently dividing cells in two 1.5-year-old macaques; at this age the SGZ contained markers of progenitors and young neurons (Extended Data Fig. 9f, g ). We checked for BrdU staining 10 and 15 weeks after five days of twice-daily BrdU (50 mg kg 
BrdU
+ cells in the GCL of these 7-year-old monkeys. Given the higher level of neurogenesis observed in the 1.5-year-old macaque, we studied one monkey at this age 2 h after a single BrdU injection. Many BrdU + cells that expressed the proliferative markers, Ki-67 and MCM2, and the progenitor marker, SOX2, were present in the SGZ (Extended Data Fig. 9h ). Finally, we compared hippocampal gene expression profiles from macaque and human (Extended Data Fig. 10) . A sharp decrease in DCX, TUJ1 and Ki-67 expression was observed in both species. In normalized developmental time, the decrease in DCX-expressing cells was accelerated in human compared to macaque (Extended Data Fig. 10 ). We conclude that there is a marked decrease in neurogenesis in the macaque DG during juvenile development, and that rare DCX +
PSA-NCAM
+ young neurons occur in adults. In the rodent brain, a proliferative SGZ consolidates around postnatal day (P)10 23, 24 , and neural stem cells within this region continue to generate new neurons into adulthood 4 . In the human brain, however, we did not find an equivalent proliferative region at any of the ages analysed. Ki-67 + cells were distributed throughout the fetal and infant hilus and GCL. The adult human SGZ was devoid of precursor cells and young neurons, and instead contained many ALDH1L1 + GFAP + cells. It is intriguing that we found rare examples of SOX2 +
Ki-67
+ cells in the adult DG, but these cells were not confined to the hilus or GCL and were BLBP − . We cannot exclude the possibility that neural stem cells in humans are BLBP − or are highly dispersed, but we did not observe DCX +
PSA-NCAM
+ cells in these samples. The simplest explanation is that these cells are dividing local glia, many of which are known to express SOX2 25, 26 (Extended Data Fig. 3c ). The lack of a coalesced SGZ could explain the absence (or rarity) of DG neurogenesis in the adult human brain.
The above findings do not support the notion that robust adult neurogenesis continues in the human hippocampus (see Supplementary Discussion).
14 C dating on sorted NeuN + nuclei 11 has suggested that many new neurons continue to be generated in the adult human hippocampus, with little decline with age, but additional evidence for high levels of progenitors or young neurons was not shown. Interestingly, considerable interindividual variation was observed in this study, and many individual samples had 14 C levels consistent with no, or little, postnatal neuronal addition. Labelled neuronal cells in the GCL in patients that received a low dose of BrdU 13 , could possibly be explained by processes not associated with cell division 27,28 (Extended Data Fig. 7f ). Other groups find a sharp decline with age in proliferation and markers of DG neurogenesis 12, 14, 29 , consistent with the above findings. It has been suggested that a few new neurons continue to be produced in adults based on DCX expression detected by PCR or western blot 14, 29, 30 . However, glial cells can express DCX 26 (Extended Data Fig. 7c -e), possibly explaining some of these expression data. The lack of young neurons in our adult human DG samples could be due to processes linked to disease and/or death. However, similar results were obtained in DG from intraoperative samples or from patients with diverse causes of death. By contrast, young neurons were found in epilepsy samples from children and in our control paediatric cases, despite diverse clinical histories. In contrast to our observations in humans, we observed a germinal SGZ in the young macaques. We found that neurogenesis continues postnatally in macaques, but like humans, this process declined in juveniles and adults, consistent with previous 3 H-thymidine and BrdU studies 2, 21, 31 . If neurogenesis continues in the adult human hippocampus, this is a rare phenomenon, raising questions of how human DG plasticity differs from other species in which adult hippocampal neurogenesis is abundant. Interestingly, a lack of neurogenesis in the hippocampus has been suggested for aquatic mammals (dolphins, porpoises and whales) 5 , species known for their large brains, longevity and complex behaviour. Understanding the limitations of adult neurogenesis in humans and other species is fundamental to interpreting findings from animal models.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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Human tissue collection. Thirty-seven post-mortem specimens from controls and twenty-two post-operative neurosurgical specimens from patients with epilepsy were collected for this study (Supplementary . (4) Specimens collected at UCLA had Institutional Review Board-approved informed consents for research along with HIPAA authorizations signed by parents or responsible guardians, as per the UCLA Human Research Protection Program. For infant cases, when the brain was at full term (37-40 gestational weeks) and autopsy was performed within two days after birth, we refer to the case as 'birth' . We collected tissue blocks from the temporal lobe, posteriorly from the amygdaloid complex to the posterior end of the inferior horn of the lateral ventricle. Autopsy samples had a post-mortem interval of less than 48 h, and samples from patients with epilepsy had less than 1 h to fixation (in 4% paraformaldehyde (PFA) or 10% formalin). For two adult brains (35-years old and 39-years old), the individuals were perfused within 3-5 h of death with 4% PFA during autopsy via the carotid artery and placed in fixative. All brains were typically cut into approximately 1.5-cm blocks, fixed in 4% PFA for an additional two days, cryoprotected in a 30% sucrose solution, and then frozen in embedding medium (OCT). Blocks were cut into 30-μ m sections on a cryostat and mounted on glass slides for immunohistochemistry. For each case, we cresyl-stained a minimum of three sections at different levels to confirm anatomical landmarks and orientation of the sample. Neurosurgical excisions of the temporal lobe, which included the hippocampus, were performed as part of resection treatment in patients with intractable epilepsy as previously described 32 . We recorded the anatomical origin of each intra-operative specimen with intra-operative neuronavigation. Intra-operative specimen assessments were independently confirmed by a neuropathologist. We performed immunohistochemistry staining on surgical sections to look for the expression of PROX1 to confirm the location of the GCL. Macaque tissue preparation. All animal care and experiments were conducted in accordance with the Fudan University Shanghai Medical College and UC Davis guidelines. Embryonic, neonatal, juvenile and adult macaque monkeys, M. mulatta, of both sexes at various ages (Supplementary Table 2 ), were obtained from the Kunming Primate Research Center of the Chinese Academy of Sciences (Kunming, China), Suzhou Xishan Zhongke Laboratory Animal Co., Ltd (Suzhou, China) and the UC Davis Primate Research Center (Davis, USA). For immunohistochemical staining, postnatal monkeys were deeply anaesthetized and then perfused with PBS followed by 4% PFA. The brains were removed and post-fixed with 4% PFA for 12-48 h. Postnatal brains were then cut coronally into approximately 1.0-2.0-cm slabs and cryoprotected in 30% sucrose in 0.1 M phosphate buffer at 4 °C for 72 h. The brain tissue samples were frozen in embedding medium (OCT) on a dry ice and ethanol slush. BrdU administration. We used five monkeys to do BrdU labelling experiments: three 1.5-year-old monkeys and two 7-7.5-year-old monkeys. BrdU acute labelling: one 1.5-year-old monkey was injected once intravenously with BrdU (50 mg kg −1 ) and euthanized 2 h after BrdU injection. BrdU birth dating: BrdU (50 mg kg −1 ) was injected intravenously twice daily for five days in two 1.5-year-old and two 7-7.5-year-old monkeys. One 1.5-year-old monkey and the 7.5-year-old monkey were euthanized 10 weeks after BrdU injections; another 1.5-year-old monkey and the 7-year-old monkey were euthanized 15 weeks after BrdU injections. We analysed 52 sections for the presence of BrdU labelling in the brain of the 7.5-yearold macaque after a 10-week delay and 76 sections of the brain of the 7-year-old after a 15-week delay. Immunohistochemistry. Frozen slides were allowed to equilibrate to room temperature for 3 h. Some antigens required antigen retrieval (Supplementary Table 3) , which was conducted at 95 °C in 10 mM sodium citrate buffer, pH 6.0. Following antigen retrieval, slides were washed with TNT buffer (0.05% Triton-X100 in PBS) for 10 min, placed in 1% H 2 O 2 in PBS for 45 min and then blocked with TNB solution (0.1 M Tris-HCl, pH 7.5, 0.15 M NaCl, 0.5% blocking reagent from PerkinElmer) for 1 h. Slides were incubated in primary antibodies overnight at 4 °C (Supplementary Table 3 ) and in biotinylated secondary antibodies (Jackson Immunoresearch Laboratories) for 2.5 h at room temperature. All antibodies were diluted in TNB solution. For most antibodies, the conditions of use were validated by the manufacturer (antibody product sheets). When this information was not provided, we performed control experiments, including no primary antibody (negative) controls and comparison to mouse staining patterns.
Sections were then incubated for 30 min in streptavidin-horseradish peroxidase, which was diluted (1:200) with TNB. Tyramide signal amplification (PerkinElmer) was used for some antigens. Sections were incubated in tyramide-conjugated fluorophores for 5 min at the following dilutions: fluorescein: 1:50; Cy3: 1:100; Cy5: 1:100. For sections that used the 3′ ,3′ -diaminobenzidine (DAB) chromagenic immunohistochemistry method, the sections were first rinsed in PBS, incubated for 15 min in 1% H 2 O 2 , then incubated for 2 h in 10% fetal calf serum as the blocking buffer. This was followed by overnight incubation with the primary antibody at 4 °C, followed by incubation with the secondary antibody for 2 h at room temperature, and development using the VECTASTAIN ABC HRP system (Vector Laboratories). After several PBS rinses, sections were dehydrated, mounted and coverslipped. Staining was conducted in technical triplicates before analysis. Fluorescent microscopy, image processing and quantifications. Images were acquired on Leica TCS SP8 or SP5 confocal microscopes using 10× (0.3 NA) or 63× (1.4 NA) objective lenses. Imaging of entire sections and for quantification of DCX + PSA-NCAM + cells was carried out at 20× (0.45 NA) magnification on a Zeiss Axiovert 200M microscope or Keyence BZ-X Analyzer (BZX700) and individual files were stitched automatically. Imaging files were analysed and quantified in Neurolucida software (MBF Bioscience, 2017 version) . Linear adjustments to image brightness and contrast were made equivalently across all images using Adobe Photoshop (CS 6). Cells were counted in Z-stack images from sections stained with Ki-67 and SOX2 or DCX and PSA-NCAM. Three to five representative images across a minimum of three evenly spaced and randomly sampled sections were collected for quantification at each age. Experimental replicates and different co-stains (in addition to the 3-5 sections included for quantifications) were also analysed for the presence or absence of young neurons or stem cells. The DG was subdivided into regions of interest (GCL, hilus or molecular layer) using DAPI to initially identify the cell-dense GCL. Each age has n = 1. Counts for cell populations were performed by three separate investigators who were blinded to individual cases. For each quantified marker, counts were repeated by different investigators for reproducibility. Fluorescence signal for single reactivity and co-localization of immunoreactivity was counted individually using the markers function in the Neurolucida imaging software. The quantification of data was performed with GraphPad Prism (v.6). No statistical methods were used to predetermine sample size. Electron microscopy. For transmission electron microscopy (TEM), samples were sectioned with a vibrating blade microtome (200 μ m) and post-fixed with 2% osmium tetroxide solution. Sections were dehydrated in increasing ethanol concentrations and stained with 2% uranyl acetate, embedded in araldite resin (Durcupan ACM Fluka, Sigma-Aldrich), and allowed to solidify at 69 °C for 72 h. We analysed 6 controls and 15 cases with epilepsy via TEM. We looked for the presence of cell clusters under light and electron microscopy in the 15 resected samples from patients with epilepsy that were 30-64 years old (at least 15 semithin sections per case) and 4 control samples from individuals that were 18-55 years old (45 semi-thin sections per case). In the additional control cases (samples from individuals that were 7 years old and 48 years old), we studied 100 semi-thin sections spanning the entirety of the anterior to posterior levels of the DG. Ultrathin sections were obtained (70 nm) for all controls and cases, and were contrasted with lead citrate solution on grids. Pre-embedding immunohisto chemistry was performed on 50-μ m floating sections with DCX and IBA1 antibodies. Post-fixation was performed with 7% glucose-1% osmium tetroxide, after which a conventional embedding protocol was followed. TEM micrographs of DCX immunolabelled ultrathin sections of the DG from individuals that were obtained at 22 gestational weeks of age (proximal edge), birth and 7 years of age were used for the GCL cellular profiles. All images were taken at the same magnification. Cell profiles were drawn on Adobe Photoshop by following the cytoplasmic cell membranes.
Cells showing DCX immunogold labelling were coloured in red. DCX − cells were identified by their ultrastructural characteristics: progenitors (light blue) had dark cytoplasm and few intermediate filaments and ensheathed DCX + cells; astrocytes (blue) had an irregular contour, star-shape morphology, light cytoplasm and intermediate filaments; mature neurons showed a large cell body with a large, round nucleus, and high amounts of ribosomes and organelles. RNAscope in situ hybridization. Sequences of target probes, preamplifier, amplifier and label probes are proprietary and commercially available (Advanced Cell Diagnostics). Typically, the probes contain 20 ZZ probe pairs (approximately 50 bp per pair) covering around 1,000 bp. Here, we used a probe against human DCX targeting 181-1381 of NM_000555.3 as a single-plex probe. Slides for in situ hybridization were initially taken from − 80 °C and dried at 60 °C for 1 h and fixed in 4% PFA for 2 h. After several PBS washes, slides were treated with ACD hydrogen peroxide for 10 min and then washed in water 2× before treatment in 1× target retrieval buffer (ACD) for 5 min (at 95-100 °C). After washing in water and then 100% alcohol, the slides were left to dry overnight before protease treatment for 15 min at 40 °C in the RNAscope oven. Hybridization of probes and amplification solutions was performed according the manufacturer's instructions. In brief, tissue sections were incubated in the desired probe (around 2-3 drops per section) for 2 h at 40 °C. The slides were washed twice in 1× wash buffer (ACD) for 2 min each. Amplification and detection steps were performed using the RNAscope 2.5 HD Red Detection Kit reagents (ACD, 320497) for single-plex probes. Sections were incubated with buffer Amp1 for 30 min at 40 °C and then washed twice in wash buffer for 2 min each. Amp2 was incubated on the sections for 15 min at 40 °C, followed by two washes in wash buffer. Sections were incubated in Amp3 for 30 min at 40 °C and washed twice in wash buffer for 2 min each, followed by incubation with Amp4 for 15 min at 40 °C. Slides were washed twice in wash buffer for 2 min each. Slides were incubated with Amp5 for 30 min at room temperature using the HybEZ humidity control tray and slide rack to maintain humidity. The slides were washed twice in 1× wash buffer for 2 min each and incubated in Amp6 for 15 min at room temperature before washing twice in wash buffer for 2 min each. The in situ hybridization signal was detected by diluting Fast RED-B in Fast RED-A solution (1:60 ratio) and incubating sections in this solution for 10 min. Slides were washed twice in water to stop the reaction.
Comparative gene transcription analysis. Developmental expression data were downloaded for human hippocampus (http://brainspan.org/; RPKM data; October 2013 release) and rhesus macaque hippocampus (http://blueprintnhpatlas.org/; March 2014 release). To compare laser-capture microdissected rhesus macaque samples to gross human hippocampus samples, we calculated average expression over all hippocampus samples for each age 33, 34 . Expression data were z-score normalized for each species and ages were aligned between species based on calculated event scores of conserved timing of neurodevelopmental events 35 . Data availability. All data and/or analyses generated during the current study are available from the corresponding author upon reasonable request. + vimentin + cells (f). These populations are asymmetrically distributed; sparse in the medial (proximal) GCL and hilus (top insets in e, f) but abundant in the lateral (distal) GCL and hilus (bottom insets in e, f). g, DCX + TUJ1 + cells and NeuN + cells in the DG at 22 gestational weeks. NeuN + GCL neurons in the distal GCL (arrow). h, A toluidine-blue-stained semi-thin section (top) and TEM micrographs showing the ultrastructural characteristics of DCX immunogold-labelled cells (pseudocoloured, bottom) at 22 gestational weeks. Insets of the semi-thin section show the proximal (1) and distal (2) ends of the GCL. Most DCX + cells in the hilus and the proximal GCL have little cytoplasm, few organelles and a small, irregular nucleus (i, ii); some DCX + cells in the hilus have an elongated, fusiform morphology (i). Some DCX + cells in the GCL have mature neuronal characteristics such as a round nucleus, more cytoplasm, ribosomes, rough endoplasmic reticulum and mitochondria (iii); this cell type was more common in the distal GCL. At this stage, the round and more mature neuronal morphologies were observed in the distal, but not in the proximal, blade. Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
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Experimental design 1. Sample size
Describe how sample size was determined.
Sample size was not predicted. This was not needed as there were no statistical comparisons performed.
Data exclusions
Describe any data exclusions.
No data was excluded.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
Experiments were repeated at minimum in triplicates.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Randomization was not relevant as no statistical analyses or comparisons were performed.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Investigators who performed quantifications were blinded on individual cases that were being analyzed. This is described in the Materials and Methods section, under "Fluorescent microscopy, image processing, and quantifications". Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.) A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided Describe the software used to analyze the data in this study.
Commercially available software, MBF Neurolucida, Graphpad Prism, and Adobe Creative Suite, and ImageJ were used. This is mentioned in relevant sections in the Materials and Methods section, with software versions annotated.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials 8. Materials availability Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a third party.
There are no restrictions to availability of human and macaque tissue used. Tissue was collected under institutional guidelines. This is described in the Materials and Methods section, under "Human Tissue Collection".
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
We generated a table (Supplementary Table 3 ) which lists every antibody used in the manuscript, the catalog number, and conditions of utilization. We have also added information re species validation, which is now included as product notes in Supplementary table 3. For most antibodies, species was validated by company and indicated (information taken from antibody product sheets). When this was not provided, we performed control experiments, including no primary antibody (negative) controls and comparison to mouse staining patterns. No eukaryotic cell lines were used.
Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
Description of research animals
Provide all relevant details on animals and/or animal-derived materials used in the study.
Animal material used in this study came from certified and regulated breeding colonies at Fudan University and the University of California, Davis. Details are described in Materials and Methods section under "Macaque Tissue Preparation" and in Supplementary 
